These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16299743)

  • 1. A two-stage analysis of repeated measurements with dropouts and/or intermittent missing data.
    Overall JE; Tonidandel S
    J Clin Psychol; 2006 Mar; 62(3):285-91. PubMed ID: 16299743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for the analysis of binary outcome results in the presence of missing data.
    Delucchi KL
    J Consult Clin Psychol; 1994 Jun; 62(3):569-75. PubMed ID: 8063983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.
    Ahn C; Tonidandel S; Overall JE
    J Biopharm Stat; 2000 May; 10(2):265-86. PubMed ID: 10803729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.
    Messer K; Vaida F; Hogan C
    Contemp Clin Trials; 2006 Dec; 27(6):506-17. PubMed ID: 16962381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On sample size calculation for 2x2 fixed-effect ANOVA when variances are unknown and possibly unequal.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):417-25. PubMed ID: 18559139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rule-of-thumb adjustment of sample sizes to accommodate dropouts in a two-stage analysis of repeated measurements.
    Overall JE; Tonidandel S; Starbuck RR
    Int J Methods Psychiatr Res; 2006; 15(1):1-11. PubMed ID: 16676681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting sample size for anticipated dropouts in clinical trials.
    Overall JE; Shobaki G; Shivakumar C; Steele J
    Psychopharmacol Bull; 1998; 34(1):25-33. PubMed ID: 9564195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of missing data in clinical research studies.
    Wisniewski SR; Leon AC; Otto MW; Trivedi MH
    Biol Psychiatry; 2006 Jun; 59(11):997-1000. PubMed ID: 16566901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case of the missing data: methods of dealing with dropouts and other research vagaries.
    Streiner DL
    Can J Psychiatry; 2002 Feb; 47(1):68-75. PubMed ID: 11873711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating age change in list recall in asset and health dynamics of the oldest-old: the effects of attrition bias and missing data treatment.
    Kennison RF; Zelinski EM
    Psychol Aging; 2005 Sep; 20(3):460-75. PubMed ID: 16248705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principal stratification designs to estimate input data missing due to death.
    Frangakis CE; Rubin DB; An MW; MacKenzie E
    Biometrics; 2007 Sep; 63(3):641-9; discussion 650-62. PubMed ID: 17824995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum sample size allocation to minimize cost or maximize power for the two-sample trimmed mean test.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):283-98. PubMed ID: 18157920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problematic formulations of SAS PROC.MIXED models for repeated measurements.
    Overall JE; Ahn C; Shivakumar C; Kalburgi Y
    J Biopharm Stat; 1999 Mar; 9(1):189-216. PubMed ID: 10091918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural equation modelling approach to the analysis of change.
    Tu YK; Baelum V; Gilthorpe MS
    Eur J Oral Sci; 2008 Aug; 116(4):291-6. PubMed ID: 18705795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.